Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Neuroscience (ANRO) Change in Accured Expenses (2023 - 2026)

Alto Neuroscience has reported Change in Accured Expenses over the past 4 years, most recently at -$1.8 million for Q1 2026.

  • Quarterly results put Change in Accured Expenses at -$1.8 million for Q1 2026, up 35.1% from a year ago — trailing twelve months through Mar 2026 was $659000.0 (down 26.78% YoY), and the annual figure for FY2025 was -$289000.0, down 107.21%.
  • Change in Accured Expenses reached -$1.8 million in Q1 2026 per ANRO's latest filing, down from $1.7 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.7 million in Q4 2025 and bottomed at -$2.7 million in Q1 2025.
  • Median Change in Accured Expenses over the past 4 years was $406000.0 (2024), compared with a mean of $123692.3.
  • Peak annual rise in Change in Accured Expenses hit 323.6% in 2025, while the deepest fall reached 765.27% in 2025.
  • Over 4 years, Change in Accured Expenses stood at -$500000.0 in 2023, then surged by 182.2% to $411000.0 in 2024, then skyrocketed by 323.6% to $1.7 million in 2025, then crashed by 200.69% to -$1.8 million in 2026.
  • Business Quant data shows Change in Accured Expenses for ANRO at -$1.8 million in Q1 2026, $1.7 million in Q4 2025, and $208000.0 in Q3 2025.